BULLA, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 15.737
EU - Europa 8.364
AS - Asia 6.897
SA - Sud America 846
Continente sconosciuto - Info sul continente non disponibili 711
AF - Africa 220
OC - Oceania 33
AN - Antartide 1
Totale 32.809
Nazione #
US - Stati Uniti d'America 15.418
SG - Singapore 2.509
IT - Italia 1.775
PL - Polonia 1.502
CN - Cina 1.410
DE - Germania 985
SE - Svezia 924
VN - Vietnam 702
BR - Brasile 634
HK - Hong Kong 613
RU - Federazione Russa 548
UA - Ucraina 542
GB - Regno Unito 516
FR - Francia 385
KR - Corea 380
BD - Bangladesh 329
FI - Finlandia 292
NL - Olanda 221
TR - Turchia 195
IN - India 171
IE - Irlanda 168
CA - Canada 163
BG - Bulgaria 130
JP - Giappone 94
AR - Argentina 72
MA - Marocco 71
TW - Taiwan 64
MX - Messico 62
ID - Indonesia 56
BE - Belgio 54
CH - Svizzera 51
ZA - Sudafrica 48
AT - Austria 47
IQ - Iraq 43
ES - Italia 42
IR - Iran 33
PK - Pakistan 32
SA - Arabia Saudita 32
AE - Emirati Arabi Uniti 31
PH - Filippine 31
EC - Ecuador 30
CL - Cile 27
AU - Australia 26
CZ - Repubblica Ceca 26
VE - Venezuela 26
PT - Portogallo 23
EG - Egitto 22
SN - Senegal 22
UZ - Uzbekistan 22
IL - Israele 20
MY - Malesia 20
CO - Colombia 19
RO - Romania 19
TH - Thailandia 19
HU - Ungheria 16
LT - Lituania 16
AZ - Azerbaigian 15
CR - Costa Rica 14
PE - Perù 14
TT - Trinidad e Tobago 14
DK - Danimarca 13
HN - Honduras 13
PY - Paraguay 13
DZ - Algeria 10
GR - Grecia 10
JM - Giamaica 10
TN - Tunisia 10
EE - Estonia 9
JO - Giordania 9
NG - Nigeria 9
OM - Oman 9
SI - Slovenia 9
EU - Europa 8
MD - Moldavia 8
PA - Panama 8
GE - Georgia 7
GT - Guatemala 7
KE - Kenya 7
LB - Libano 7
NP - Nepal 7
HR - Croazia 6
LV - Lettonia 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
RS - Serbia 6
BO - Bolivia 5
CI - Costa d'Avorio 5
ET - Etiopia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LK - Sri Lanka 5
NO - Norvegia 5
SV - El Salvador 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
KW - Kuwait 4
AM - Armenia 3
BB - Barbados 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 32.062
Città #
Ashburn 1.825
Singapore 1.514
Warsaw 1.349
Fairfield 1.267
Woodbridge 1.082
Ann Arbor 882
San Jose 867
Houston 775
Chandler 724
Hong Kong 575
Wilmington 549
Dallas 546
Seattle 530
Trieste 504
Jacksonville 445
Cambridge 424
Seoul 367
Beijing 344
Council Bluffs 331
Hefei 293
Boardman 244
Princeton 229
Santa Clara 226
Los Angeles 222
Columbus 204
Chicago 199
Ho Chi Minh City 199
New York 168
Hanoi 148
Dublin 144
The Dalles 135
Moscow 133
Izmir 132
Sofia 128
Lauterbourg 123
Milan 119
Zgierz 115
Buffalo 110
Helsinki 108
London 102
Frankfurt am Main 99
Munich 80
Dearborn 71
San Diego 70
São Paulo 70
Phoenix 60
Shanghai 60
Taipei 58
Atlanta 55
Casablanca 53
Tokyo 53
Dong Ket 49
Falls Church 49
North Bergen 45
Rome 45
Bern 43
Düsseldorf 42
Brussels 40
Boston 39
Toronto 39
Washington 39
Da Nang 38
Orem 37
Montreal 36
Amsterdam 33
Turku 33
Des Moines 32
Guangzhou 31
Menlo Park 31
Redmond 31
Redondo Beach 31
Miano 30
Stockholm 30
Nuremberg 29
Redwood City 29
San Francisco 29
Denver 28
Brooklyn 27
Venice 27
Vienna 27
Chennai 26
Saint Petersburg 26
Nanjing 25
Miami 24
Fort Wayne 23
Haiphong 23
Jakarta 23
Jinan 23
Dakar 22
Johannesburg 22
Lappeenranta 22
Kyiv 21
Poplar 21
Arzene 20
Baghdad 20
Memphis 20
Treviso 20
Rio de Janeiro 19
Belo Horizonte 18
Fremont 18
Totale 20.565
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 879
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 530
RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? 501
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 452
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 414
HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1 385
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 377
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 369
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 348
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 339
C1q is involved in human trophoblast invasion 332
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 329
Pre-eclampsia affects procalcitonin production in placental tissue 326
Analysis of anti-C1q antibodies in normal and pathological pregnancies 323
Pathological significance and prognostic value of surfactant protein D in cancer 320
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 317
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 314
C1q is associated with a reduced inflammatory response of decidual endothelial cells 312
C1q is responsible of the anti-inflammatory behavior of decidual endothelial cells 304
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 303
C1q: A novel angiogenic factor? 296
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 292
Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells 287
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 284
Alternative functions of the complement protein C1q at embryo implantation site 278
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 270
The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. 269
MALIGNANT PLEURAL MESOTHELIOMA WITH “SIGNETRING” CELLS: A DIAGNOSTIC CHALLENGE AND AN UNUSUAL CASE REPORT 266
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 266
Combined extracts of Echinacea angustifolia DC. and Zingiber officinale Roscoe in softgel capsules: Pharmacokinetics and immunomodulatory effects assessed by gene expression profiling 265
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 265
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 264
null 263
Analysis of the cAMP-PCT-CGRP axis in normal and pathological pregnancy 262
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 259
Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules 251
Evaluation of Sars-CoV-2 entry receptors in COVID-19 positive and negative placentae: correlation between expression and infectivity 249
The role of complement component C1q in angiogenesis 246
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 244
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia 244
Placental trophoblast and endothelial cells as target of maternal immune response. 242
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP 239
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 236
THE CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCES OF C1Q EXPRESSION IN GLIOMAS: A BIOINFORMATICS ANALYSIS 226
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 222
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 222
Differential capability of clinically employed dermal regeneration scaffolds to support vascularization for tissue bioengineering 221
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 220
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 215
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 214
Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating 212
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 209
Preeclampsia is associated with defective production of C1q by invasive trophoblast 209
In vivo distribution of {beta}2 glycoprotein I under various pathophysiological conditions 208
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 208
A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients 203
Emerging Roles of the Complement System at Foeto-maternal Interface 203
Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells 203
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 201
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine 201
The complement system at the embryo implantation site 200
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 199
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 197
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 196
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 196
Analysis of the molecular mechanisms of C1-inhibitor deficiency induced angioedema 196
Overview of procalcitonin in pregnancy and in pre-eclampsia 196
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 195
[The maternal-fetal immune relationship in pregnancy] 192
Complement activation in animal and human pregnancies as a model for immunological recognition 191
A non-redundant role of complement protein C1q in normal and adverse pregnancy 188
Endothelial cell supplementation promotes xenograft revascularization during short-term ovarian tissue transplantation 188
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 187
Surfactant protein D in immune surveillance against cancer 187
Proangiogenic properties of complement protein C1q can contribute to endometriosis 186
C1q as pro-angiogenic factor in the context of ovarian tissue transplantation 186
Prevalence and biological effects of anti-trophoblast and anti-endothelial cell antibodies in patients with recurrent spontaneous abortions. 186
Human eosinophil peroxidase enhances tumor necrosis factor and hydrogen peroxide release by human monocyte-derived macrophages 184
Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels 183
”Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflamation”F.Fischetti, R. Carretta, G. Borotto, P. Durigutto, R. Bulla, P.L. Meroni, F. Tedesco. 183
At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy Success 183
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 181
Prognostic Implications of the Complement Protein C1q in Gliomas 181
The Complement System at the Embryo Implantation Site: Friend or Foe? 179
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 178
C1q induces in vivo angiogenesis and promotes wound healing 177
The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system 177
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells 173
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 172
An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. 171
COVID-19, Pre-Eclampsia, and Complement System 170
Effect of a standardized liver and spleen fraction of peptides on the differentiation of human monocyte derived macrophages. 165
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment 164
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 164
Epigenetic regulation of complement C1Q gene expression 162
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 161
null 161
Study of the prognostic significance of the protein C1q in carcinomas 161
Feto-maternal immune interaction at the placental level 160
Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models 160
Totale 24.624
Categoria #
all - tutte 89.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.587 0 0 0 123 77 174 113 86 241 191 136 446
2022/20232.400 232 326 177 345 213 401 32 211 273 32 108 50
2023/20241.828 148 97 154 119 158 203 307 265 58 75 136 108
2024/20253.654 81 126 282 263 330 349 248 205 509 456 371 434
2025/20269.874 972 618 772 934 812 823 1.435 280 983 1.247 587 411
2026/20272.296 615 542 617 522 0 0 0 0 0 0 0 0
Totale 32.809